[Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]
- PMID: 17128669
[Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis]
Abstract
Multiple sclerosis is an autoimmune disease characterized by demyelination and axonal loss. Conventional magnetic resonance imaging allows the demonstration of spatial and temporal dissemination of multiple sclerosis lesions earlier than is possible from clinical assessments. A variety of conventional magnetic resonance imaging protocols, in conjunction with clinical assessment, are now routinely used to increase the accuracy of diagnosis and long-term prognosis of multiple sclerosis. T2-weighted hyperintense lesions are related primarily to increased water content and thus cannot distinguish between inflammation, edema, demyelination, Wallerian degeneration, and axonal loss, whereas the contrast gadolinium-enhanced lesions on T1-weighted images reflect increased blood-brain barrier permeability associated with active inflammatory activity. Conventional magnetic resonance imaging metrics are not sufficiently sensitive to detect invisible brain damage in the normal appearing brain tissue, and they do not show a reliable correlation with clinical measures of disability. However, numerous studies showed that they can improve accuracy in the diagnosis and prognosis of multiple sclerosis. Recently, non-conventional magnetic resonance imaging techniques have been introduced to increase the accuracy of diagnosis and prognosis of multiple sclerosis. Several studies have used brain atrophy, T1-hypointense lesion volume, magnetization transfer imaging, diffusion-weighted imaging and magnetic resonance spectroscopy to test whether the extent and severity of tissue loss in lesions and in normal appearing gray and white matter at the time of clinically isolated syndrome may have diagnostic and prognostic value. These magnetic resonance imaging techniques represent a powerful tool to non-invasively study different pathological substrates of lesions and microscopic tissue changes. Additional short- and long-term prospective studies are requested to establish their value in the diagnosis and prognosis of multiple sclerosis.
Similar articles
-
Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1675-86. doi: 10.1098/rstb.1999.0511. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603619 Free PMC article. Review.
-
MR in the diagnosis and monitoring of multiple sclerosis: an overview.Eur J Radiol. 2008 Sep;67(3):409-14. doi: 10.1016/j.ejrad.2008.02.044. Epub 2008 Apr 22. Eur J Radiol. 2008. PMID: 18434066 Review.
-
Neuroimaging in multiple sclerosis.Int Rev Neurobiol. 2007;79:449-74. doi: 10.1016/S0074-7742(07)79020-7. Int Rev Neurobiol. 2007. PMID: 17531854 Review.
-
Clinical-magnetic resonance imaging correlations in multiple sclerosis.J Neuroimaging. 2005;15(4 Suppl):10S-21S. doi: 10.1177/1051228405283291. J Neuroimaging. 2005. PMID: 16385015 Review.
-
[Magnetic resonance imaging in multiple sclerosis].Pathol Biol (Paris). 2000 Mar;48(2):151-61. Pathol Biol (Paris). 2000. PMID: 10815291 Review. French.
Cited by
-
Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques.J Family Med Prim Care. 2019 Jul;8(7):2409-2413. doi: 10.4103/jfmpc.jfmpc_420_19. J Family Med Prim Care. 2019. PMID: 31463267 Free PMC article.
-
Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2119-24. doi: 10.3174/ajnr.A3539. Epub 2013 May 30. AJNR Am J Neuroradiol. 2013. PMID: 23721894 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical